282
Views
51
CrossRef citations to date
0
Altmetric
Original Research

A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells

, , , , , , & show all
Pages 4029-4044 | Published online: 31 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Yadollah Omidi, Maha Mobasher, Ana M. Castejon & Morteza Mahmoudi. (2022) Recent advances in nanoscale targeted therapy of HER2-positive breast cancer. Journal of Drug Targeting 30:7, pages 687-708.
Read now
Cheng-Wu Zhang, Jun-Gang Zhang, Xue Yang, Wen-Lin Du, Zi-Lin Yu, Zhen-Ye Lv & Xiao-Zhou Mou. (2022) Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices. Expert Opinion on Drug Delivery 19:6, pages 623-640.
Read now
Sahar Porrang, Soodabeh Davaran, Nader Rahemi, Somaiyeh Allahyari & Ebrahim Mostafavi. (2022) How Advancing are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature. International Journal of Nanomedicine 17, pages 1803-1827.
Read now
Haocheng Qin, Rong Teng, Yan Liu, Juan Li & Ming Yu. (2022) Drug Release from Gelsolin-Targeted Phase-Transition Nanoparticles Triggered by Low-Intensity Focused Ultrasound. International Journal of Nanomedicine 17, pages 61-71.
Read now
Jialang Zhuang, Siqi Chen, Ye Hu, Fan Yang, Qin Huo & Ni Xie. (2021) RETRACTED ARTICLE: Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer. International Journal of Nanomedicine 16, pages 1961-1976.
Read now
Ruifeng Wu, Zhiqiang Zhang, Baohua Wang, Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao & Lei Wang. (2020) Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles. Drug Design, Development and Therapy 14, pages 2249-2261.
Read now
Jian Lin, Zhiqi He, Fen Liu, Jie Feng, Chengyi Huang, Xueli Sun & Hui Deng. (2020) Hybrid Hydrogels for Synergistic Periodontal Antibacterial Treatment with Sustained Drug Release and NIR-Responsive Photothermal Effect. International Journal of Nanomedicine 15, pages 5377-5387.
Read now

Articles from other publishers (44)

Mahavir Narwade, Aazam Shaikh, Kavita R. Gajbhiye, Prashant Kesharwani & Virendra Gajbhiye. (2023) Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery. Biomaterials Research 27:1.
Crossref
Shiming He, Yue Du, Hongyu Tao & Huaiyu Duan. (2023) Advances in aptamer-mediated targeted delivery system for cancer treatment. International Journal of Biological Macromolecules 238, pages 124173.
Crossref
Anastasiya N. Shishparenok, Vitalina V. Furman & Dmitry D. Zhdanov. (2023) DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors. Cancers 15:7, pages 2151.
Crossref
Neha Benedicta Fernandes, Yogendra Nayak, Sanjay Garg & Usha Y Nayak. (2023) Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives. Coordination Chemistry Reviews 478, pages 214977.
Crossref
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida & Mohd Imran. (2023) Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11:2, pages 473.
Crossref
Ruma Rani, Parth Malik, Sunena Dhania & Tapan Kumar Mukherjee. (2023) Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment. Pharmaceutics 15:1, pages 227.
Crossref
Mohammad Banazadeh, Mohammad Mohajeri, Kiarash Saleki, Behzad Behnam, Yong Teng, Prashant Kesharwani & Amirhossein Sahebkar. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 237 253 .
Xueqi Hu, Dongdong Zhang, Zheng Zeng, Linjie Huang, Xiahui Lin & Shanni Hong. (2022) Aptamer-Based Probes for Cancer Diagnostics and Treatment. Life 12:11, pages 1937.
Crossref
Bi-Lian Li, Chun-Lei Wang, Qin Wang, Jian-Mei Yang, Shao-Ming Chi, Jian-Chong Chen, Jin Zhang & Yan Zhao. (2022) β-Cyclodextrin-based supramolecular nanoparticles: pH-sensitive nanocarriers for the sustained release of anti-tumor drugs. New Journal of Chemistry 46:45, pages 21823-21833.
Crossref
Prashant Pandey, Dilip Kumar Arya, Mohan Kumar Ramar, Kumarappan Chidambaram & P.S. Rajinikanth. (2022) Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy. Drug Discovery Today 27:9, pages 2526-2540.
Crossref
Kousar Ghasemii, Mahdieh Darroudi, Ilnaz Rahimmanesh, Matineh Ghomi, Mahnaz Hassanpour, Esmaeel Sharifi, Satar Yousefiasl, Sepideh Ahmadi, Ali Zarrabi, Assunta Borzacchiello, Mohammad Rabiee, Ana Cláudia Paiva-Santos & Navid Rabiee. (2022) Advances in aptamer-based drug delivery vehicles for cancer therapy. Biomaterials Advances 140, pages 213077.
Crossref
Li Zhang, Xiaohui Bai, Rongrong Wang, Lulu Xu, Jingyu Ma, Yue Xu & Zhiming Lu. (2022) Advancements in the studies of novel nanomaterials for inner ear drug delivery. Nanomedicine 17:20, pages 1463-1475.
Crossref
Hang Chen, Shurui Zhang, Yung-Chin Hsiao, Qun Wang, Jau-Song Yu & Wanming Li. (2022) Graphene Oxide and Fluorescent-Aptamer-Based Novel Aptasensors for Detection of Metastatic Colorectal Cancer Cells. Polymers 14:15, pages 3040.
Crossref
María Vallet-Regí, Ferdi Schüth, Daniel Lozano, Montserrat Colilla & Miguel Manzano. (2022) Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?. Chemical Society Reviews 51:13, pages 5365-5451.
Crossref
Yehong Liu, Miaoxin Chen, Gaoyang Li, Shouhong Xu & Honglai Liu. (2022) Construction of pH/reduction dual responsive MSN-HAgel containing HApt for tumor targeting carriers. RSC Advances 12:30, pages 19063-19071.
Crossref
Leopoldo Sitia, Marta Sevieri, Lorena Signati, Arianna Bonizzi, Arianna Chesi, Francesco Mainini, Fabio Corsi & Serena Mazzucchelli. (2022) HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment. Cancers 14:10, pages 2424.
Crossref
Ana Isabel Fraguas-Sánchez, Irene Lozza & Ana Isabel Torres-Suárez. (2022) Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 14:5, pages 1198.
Crossref
Albert Yu, Xiaoyong Dai, Zixian Wang, Huaqing Chen, Bing Guo & Laiqiang Huang. (2022) Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 12:2, pages 109.
Crossref
Jun Xu, Yehong Liu, Gaoyang Li, Mingxia Peng, Shouhong Xu & Honglai Liu. (2022) A reduction-triggered nanocarrier based on host–guest interaction between pillar[5]arene derivative and viologen on MSN for intracellular delivery. Journal of Drug Delivery Science and Technology 68, pages 103055.
Crossref
Rahul Tiwari, Arvind Gulbake, Pramod Kumar, Anamika Sahu Gulbake, Rupa Gupta, Dheeraj Bisht & Neeraj Kumar Sethiya. 2022. Pharmaceutical Nanobiotechnology for Targeted Therapy. Pharmaceutical Nanobiotechnology for Targeted Therapy 93 122 .
Haregewoin Bezu Woldekidan, Adugna A. Woldesemayat, Getachew Adam, Mesfin Tafesse & Deepak B. Thimiri Govinda Raj. 2023. Cell Biology and Translational Medicine, Volume 18. Cell Biology and Translational Medicine, Volume 18 173 192 .
Jun Xu, Gaoyang Li, Yuhua Zhang, Yuhan Kang, Shouhong Xu & Honglai Liu. (2021) A dual-responsive drug delivery system based on mesoporous silica nanoparticles covered with zipper-type peptide for intracellular transport/release. Colloids and Surfaces A: Physicochemical and Engineering Aspects 631, pages 127672.
Crossref
Kristina Živojević, Minja Mladenović, Mila Djisalov, Mirjana Mundzic, Eduardo Ruiz-Hernandez, Ivana Gadjanski & Nikola Ž. Knežević. (2021) Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications. Journal of Controlled Release 337, pages 193-211.
Crossref
Sonia Iranpour, Ahmad Reza Bahrami, Amir Sh. Saljooghi & Maryam M. Matin. (2021) Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy. Coordination Chemistry Reviews 442, pages 213949.
Crossref
Palani Sharmiladevi, Koyeli Girigoswami, Viswanathan Haribabu & Agnishwar Girigoswami. (2021) Nano-enabled theranostics for cancer. Materials Advances 2:9, pages 2876-2891.
Crossref
Alex N. Frickenstein, Jordan M. Hagood, Collin N. Britten, Brandon S. Abbott, Molly W. McNally, Catherine A. Vopat, Eian G. Patterson, William M. MacCuaig, Ajay Jain, Keisha B. Walters & Lacey R. McNally. (2021) Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect. Pharmaceutics 13:4, pages 570.
Crossref
Arezoo Sodagar Taleghani, Ali Taghvaie Nakhjiri, Mohammad Javad Khakzad, Seyed Mahdi Rezayat, Pedram Ebrahimnejad, Amir Heydarinasab, Azim Akbarzadeh & Azam Marjani. (2021) Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review. Journal of Molecular Liquids 328, pages 115417.
Crossref
Min Zhu & Shan Wang. (2021) Functional Nucleic‐Acid‐Decorated Spherical Nanoparticles: Preparation Strategies and Current Applications in Cancer Therapy. Small Science 1:3.
Crossref
Elnaz Bagheri, Mona Alibolandi, Khalil Abnous, Seyed Mohammad Taghdisi & Mohammad Ramezani. (2021) Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles. Journal of Materials Chemistry B 9:5, pages 1351-1363.
Crossref
Balney Rajitha, Rama Rao Malla, Ramakrishna Vadde, Prameswari Kasa, Ganji Lakshmi Vara Prasad, Batoul Farran, Seema Kumari, Eluri Pavitra, Mohammad Amjad Kamal, Ganji Seeta Rama Raju, Sujatha Peela & Ganji Purnachandra Nagaraju. (2021) Horizons of nanotechnology applications in female specific cancers. Seminars in Cancer Biology 69, pages 376-390.
Crossref
Fahimeh Charbgoo, Fatemeh Soltani, Mona Alibolandi, Seyed Mohammad Taghdisi, Khalil Abnous, Pouria Ramezani & Mohammad Ramezani. (2021) Ladder-like targeted and gated doxorubicin delivery using bivalent aptamer in vitro and in vivo. Materials Science and Engineering: C 119, pages 111618.
Crossref
Khaled AbouAitah & Witold Lojkowski. (2021) Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy. Pharmaceutics 13:2, pages 143.
Crossref
Jiafeng Zhuang, Lina Zhou, Wen Tang, Tonghao Ma, Hui Li, Xiaoli Wang, Chao Chen & Ping Wang. (2021) Tumor targeting antibody-conjugated nanocarrier with pH/thermo dual-responsive macromolecular film layer for enhanced cancer chemotherapy. Materials Science and Engineering: C 118, pages 111361.
Crossref
Bingren Tian, Yumei Liu & Jiayue Liu. (2021) Smart stimuli-responsive drug delivery systems based on cyclodextrin: A review. Carbohydrate Polymers 251, pages 116871.
Crossref
Ge Yang & Yuanyu Huang. 2021. Aptamers for Medical Applications. Aptamers for Medical Applications 129 178 .
Berrin Küçüktürkmen & Jessica M. Rosenholm. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy 99 120 .
Gema Vivo‐Llorca, Vicente Candela‐Noguera, María Alfonso, Alba García‐Fernández, Mar Orzáez, Félix Sancenón & Ramón Martínez‐Máñez. (2020) MUC1 Aptamer‐Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple‐Negative Breast Cancer. Chemistry – A European Journal 26:69, pages 16318-16327.
Crossref
Jorge L. Sánchez-Orozco, Bertha Puente-Urbina, J. Alfonso Mercado-Silva & H. Iván Meléndez-Ortiz. (2020) β-Cyclodextrin-functionalized mesocellular silica foams as nanocarriers of doxorubicin. Journal of Solid State Chemistry 292, pages 121728.
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. International Journal of Molecular Sciences 21:23, pages 9123.
Crossref
Jitendra Wankar, Niranjan G. Kotla, Sonia Gera, Swetha Rasala, Abhay Pandit & Yury A. Rochev. (2020) Recent Advances in Host–Guest Self‐Assembled Cyclodextrin Carriers: Implications for Responsive Drug Delivery and Biomedical Engineering. Advanced Functional Materials 30:44, pages 1909049.
Crossref
Sho Ueno, Min Woo Kim, Gibok Lee, Yong Il Park, Takuro Niidome & Ruda Lee. (2020) Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics 12:6, pages 585.
Crossref
Sugata Barui & Valentina Cauda. (2020) Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy. Pharmaceutics 12:6, pages 527.
Crossref
Massimiliano Magro, Andrea Venerando, Alberto Macone, Gianluca Canettieri, Enzo Agostinelli & Fabio Vianello. (2020) Nanotechnology-Based Strategies to Develop New Anticancer Therapies. Biomolecules 10:5, pages 735.
Crossref
Dipak Dilip Gadade & Sanjay Sudhakar Pekamwar. (2020) Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics. Advanced Pharmaceutical Bulletin 10:2, pages 166-183.
Crossref